CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed for extended half-life via DAC (Drug Affinity Complex) modification. Researchers use CJC-1295 in preclinical settings to investigate pulsatile GH axis signaling, IGF-1 pathway dynamics, and downstream effects on protein synthesis and metabolism.
CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed for extended half-life via DAC (Drug Affinity Complex) modification. Researchers use CJC-1295 in preclinical settings to investigate pulsatile GH axis signaling, IGF-1 pathway dynamics, and downstream effects on protein synthesis and metabolism.